A61P 5/18
Drugs for disorders of the endocrine system: of the parathyroid hormones
Official title: of the parathyroid hormones
A61P5/18 (Drugs for disorders of the endocrine system: of the parathyroid hormones) appears on 916 US grants and 1,381 published applications in this corpus.
Search patents in A61P- Granted patents
- 916
- Published applications
- 1,381
- Assignees
- 476
- Inventors
- 2,141
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 11 | 0 |
| 2000 | 15 | 0 |
| 2001 | 20 | 7 |
| 2002 | 23 | 25 |
| 2003 | 22 | 50 |
| 2004 | 15 | 54 |
| 2005 | 22 | 54 |
| 2006 | 26 | 50 |
| 2007 | 27 | 73 |
| 2008 | 16 | 52 |
| 2009 | 29 | 86 |
| 2010 | 45 | 97 |
| 2011 | 39 | 75 |
| 2012 | 51 | 74 |
| 2013 | 76 | 91 |
| 2014 | 75 | 109 |
| 2015 | 60 | 70 |
| 2016 | 65 | 65 |
| 2017 | 44 | 63 |
| 2018 | 41 | 51 |
| 2019 | 54 | 51 |
| 2020 | 28 | 52 |
| 2021 | 32 | 23 |
| 2022 | 17 | 28 |
| 2023 | 17 | 25 |
| 2024 | 15 | 21 |
| 2025 | 15 | 17 |
| 2026 | 4 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same18 Aug 2026US 12,708,625 B2Dongguk University Industry-Academic Cooperation Foundation
- Methods and compositions for reducing parathyroid levels18 Aug 2026US 12,708,629 B2Eirgen Pharma Ltd.
- PD-1-binding molecules and methods of use thereof27 Jan 2026US 12,534,531 B2MacroGenics, Inc.
- Stable levothyroxine compositions in aprotic polar solvents6 Jan 2026US 12,514,837 B2Xeris Pharmaceuticals, Inc.
- Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid30 Dec 2025US 12,508,231 B2Vertex Pharmaceuticals Incorporated
- Treatment of hypoparathyroidism using triphenyl calcilytic compounds1 Oct 2026US 2026/0294857 A1Calcilytix Therapeutics, Inc.
- Polypeptide pharmaceuticals27 Aug 2026US 2026/0248925 A1Mederis Diabetes LLC
- Pth analogs for the treatment of hypoparathyroidism6 Aug 2026US 2026/0224716 A1Indiana University Research and Technology Corporation
- Pharmaceutical compositions of polymeric micellar cinacalcet, and methods of preparation and use thereof16 Jul 2026US 2026/0199234 A1Hangzhou Shixi Pharmaceutical Technology Co., Ltd.
- Formulations comprising a combination of acid-neutralizing polymeric and non-polymeric substances for oral administration of active agents2 Jul 2026US 2026/0183242 A1Entera Bio Ltd.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Dosage forms of risedronate155US 5,622,721 AThe Procter & Gamble Company · 1997
- Swallowable drug delivery device and methods of drug delivery154US 8,721,620 B2Rani Therapeutics, LLC · 2014
- Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters130US 7,846,951 B2Vertex Pharmaceuticals Incorporated · 2010
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010